Skip to content
Use caution Drug recall · FDA · Published February 13, 2015

Qualitest Recalls Amlodipine 10mg Tablets Due to Oversized Tablets

Qualitest Pharmaceuticals is recalling one lot of 10 mg Amlodipine Besylate tablets because they contain oversized tablets. Check your bottle's lot number.

🇺🇸 FDA recall #D-0397-2015DrugQualitest Pharmaceuticals ›
Take action

Contact the company

Recalling firmQualitest Pharmaceuticals120 Vintage Dr NE · Huntsville, AL 35811-8216
✎ GovInfoNow plain-language explainer

What happened, in plain English

Qualitest Pharmaceuticals has recalled one lot of 10 mg Amlodipine Besylate Tablets USP sold in 1000-count bottles. The recall was initiated because the tablets in this specific lot were found to be oversized, failing tablet specifications. This defect could potentially affect how the medication is taken or absorbed. Read more at govinfonow.com/recall/44928-qualitest-pharmaceuticals-recalls-amlodipine-besylate-tablets-usp-10-mg-1000.

Source Summary by GovInfoNow · govinfonow.com/recall/44928-qualitest-pharmaceuticals-recalls-amlodipine-besylate-tablets-usp-10-mg-1000 · Updated October 12, 2026 · FDA enforcement record: FDA #D-0397-2015

Cite this page

“Qualitest Recalls Amlodipine 10mg Tablets Due to Oversized Tablets.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44928-qualitest-pharmaceuticals-recalls-amlodipine-besylate-tablets-usp-10-mg-1000. Based on FDA recall #D-0397-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0397-2015%22&limit=1).

Why it’s dangerous

The recalled tablets are oversized, which deviates from the established tablet specifications for this drug product. While the record does not specify exact health consequences, deviations in tablet size can impact dosing accuracy or patient compliance.

Who’s affected

Patients who have been prescribed Amlodipine Besylate 10 mg tablets from Qualitest Pharmaceuticals and possess a bottle with lot number T018H14A. These individuals are at risk of receiving medication that does not meet standard physical specifications.

How to tell if you have this one

Check your medication bottle for the National Drug Code (NDC) 0603-2110-32 and the lot number T018H14A. The product is Amlodipine Besylate Tablets USP, 10 mg, in 1000-count bottles. The expiration date on the bottle is 08/16.

  • Brand
    Qualitest Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your medication

    Verify if your Amlodipine Besylate Tablets have NDC 0603-2110-32 and lot number T018H14A.

  2. Contact your pharmacist

    Speak with your healthcare provider or pharmacist to determine the appropriate next steps for your prescription.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 11 months after the firm started it.

1. Firm started the recall: Feb 13, 201512. FDA classified it Class II: Mar 3, 201523. Published in FDA’s Enforcement Report: Mar 11, 201534. FDA terminated the recall: Jan 27, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0397-2015 (February 13, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0397-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA